The Patent Finder

Somatogenetics International, Inc.

Also on record
Records under this name other than patents Somatogenetics International, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Somatogenetics International, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 4,863,932Squalene oxide cyclase inhibitors and therapeutic use thereof
Formerly held
Term ended
Term ended no later than Sep 5, 2009 · Low confidence
Term endedTerm ended no later than Sep 5, 2009Low confidence
US 5,028,588Blood substitutes
Formerly held
Term ended
Term ended no later than Jul 2, 2011 · Low confidence
Term endedTerm ended no later than Jul 2, 2011Low confidence
US 5,449,759Hemoglobins with intersubunit desulfide bonds
Formerly held
Term ended
Term ended no later than Sep 12, 2015 · Low confidence
Term endedTerm ended no later than Sep 12, 2015Low confidence
US 5,563,254Polynucleotides encoding genetically engineered mutant hemoglobins
Formerly held
Term ended
Term ended no later than Oct 8, 2016 · Low confidence
Term endedTerm ended no later than Oct 8, 2016Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited